Abstract
The use of the oxime P2S as intravenous therapy for organophosphorus anticholinesterase poisoning is well known. In emergency situations this route of administration may prove impractical due to severe symptoms of anticholinesterase poisoning and therefore the intramuscular route is to be preferred. The absolute intramuscular dose of P2S per man, recommended as necessary for adequate therapy of anticholinesterase poisoning, is 500 mg. In practical situations this dose may have to be repeated at intervals resulting in overdosage, and therefore, the clinical side-effects which this regimen might have on normal subjects has been determined. It has also been suggested that where organophosphorus anticholinesterase compounds are handled continuously for many months in the year, for example, in crop spraying and in industry, P2S might be taken prophylactically.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARKMAN R., EDGREN B., SUNDWALL A. SELF-ADMINISTRATION OF PRALIDOXIME IN NERVE GAS POISONING WITH A NOTE ON THE STABILITY OF THE DRUG. J Pharm Pharmacol. 1963 Oct;15:671–677. doi: 10.1111/j.2042-7158.1963.tb12859.x. [DOI] [PubMed] [Google Scholar]
- COLEMAN I. W., LITTLE P. E., GRANT G. A. Oral prophylaxis for anticholinesterase poisoning. Can J Biochem Physiol. 1961 Feb;39:351–363. doi: 10.1139/o61-035. [DOI] [PubMed] [Google Scholar]
- CREASEY N. H., GREEN A. L. 2-Hydroxyiminomethyl-N-methylpyridinium methanesulphonate (P2S), an antidote to organophosphorus poisoning. Its preparation, estimation and stability. J Pharm Pharmacol. 1959 Aug;11:485–490. doi: 10.1111/j.2042-7158.1959.tb12586.x. [DOI] [PubMed] [Google Scholar]
- CROOK J. W., GOODMAN A. I., COLBOURN J. L., ZVIRBLIS P., OBERST F. W., WILLS J. H. Adjunctive value of oral prophylaxis with the oximes 2-PAM lactate and 2-PAM methanesulfonate to therapeutic administration of atropine in dogs poisoned by inhaled Sarin vapor. J Pharmacol Exp Ther. 1962 Jun;136:397–399. [PubMed] [Google Scholar]
- Calesnick B., Christensen, Richter M. Human toxicity of various oximes. 2-Pyridine aldoxime methyl chloride, its methane sulfonate salt, and 1,1'-trimethylenebis-(4-formylpyridinium chloride). Arch Environ Health. 1967 Nov;15(5):599–608. doi: 10.1080/00039896.1967.10664975. [DOI] [PubMed] [Google Scholar]
- DAVIES D. R., GREEN A. L., WILLEY G. L. 2-Hydroxyiminomethyl-N-methylpyridinium methanesulphonate and atropine in the treatment of severe organophosphate poisoning. Br J Pharmacol Chemother. 1959 Mar;14(1):5–8. doi: 10.1111/j.1476-5381.1959.tb00920.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quinby G. E. Feasibility of prophylaxis by oral pralidoxime. Cholinesterase inactivation by organophosphorus pesticides. Arch Environ Health. 1968 Jun;16(6):812–820. doi: 10.1080/00039896.1968.10665158. [DOI] [PubMed] [Google Scholar]
- Sidell F. R., Groff W. A., Kaminskis A. Pralidoxime methanesulfonate: plasma levels and pharmacokinetics after oral administration to man. J Pharm Sci. 1972 Jul;61(7):1136–1140. doi: 10.1002/jps.2600610722. [DOI] [PubMed] [Google Scholar]
- Taylor W. J., Llewellyn-Thomas E., Sellers E. A., Walker G. C. Effects of a combination of atropine, metaraminol and pyridine aldoxime methanesulfonate (AMP therapy) on normal human subjects. Can Med Assoc J. 1965 Oct 30;93(18):957–961. [PMC free article] [PubMed] [Google Scholar]